Medicine
fromInsideHook
2 days agoEli Lilly Weight Loss Drug Shows Impressive Results in Phase 3 Trial
Retatrutide, a GIP/GLP-1/glucagon triple receptor agonist, produced substantial weight loss and reduced pain while improving function in obese patients with knee osteoarthritis.